Valeant Missed Out On Botox But Hits With Other Buys

If not for acquisitions, Valeant Pharmaceuticals (VRX) would hardly make it on a map of large and fast-growing drug companies. But not only has it earned a spot on such a map, it is all over the map. It sells everything from cancer and neurology drugs to cold remedies and toenail fungal solutions. "We have thousands of products around the world," said Michael Pearson, Valeant's CEO. "We are very diversified. We're like a little Johnson & Johnson

What feeling does this article give you?

#hashtags to follow:

Valeant Pharmaceuticals [+]    VRX [+]    Michael Pearson [+]    Valeant [+]    Johnson [+]   

More #news: